EXHIBIT 10.19 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. CO-EXCLUSIVE LICENSE AGREEMENT between Garching Innovation GmbH, Hofgartenstrasse 8, 80539 Munchen, Germany,...Co-Exclusive License Agreement • May 21st, 2004 • Alnylam Pharmaceuticals Inc • Pharmaceutical preparations
ContractCo-Exclusive License Agreement • May 5th, 2020 • Massachusetts
EX-10.4 5 b85475exv10w4.htm EX-10.4 Exhibit 10.4 AMENDMENT TO CO-EXCLUSIVE LICENSE AGREEMENT This Amendment to the Alnylam Co-Exclusive License Agreement is made as of March 14, 2011 (“Effective Date”), by and between Alnylam Pharmaceuticals, Inc. (“Alnylam”), on the one hand, and Whitehead Institute for Biomedical Research (“Whitehead”), Massachusetts Institute of Technology (“MIT”), and Max-Planck-Innovation GmbH (“MI”). This agreement is made with respect to the following recitals: WHEREAS, Alnylam and MI (at the time called Garching Innovation GmbH and referred to as GI in the Alnylam Co-Exclusive License Agreement) are parties to the Alnylam Co-Exclusive License Agreement; WHEREAS, Whitehead and MIT joined the Alnylam Co-Exclusive License Agreement on July 30, 2003; WHEREAS, the Alnylam Co-Exclusive License Agreement grants, among other things, a license to the “MAX PLANCK PATENT RIGHTS” (as that term is defined in the Alnylam Co-Exclusive License Agreement) to Alnylam, subject to
EX-10.10 12 d42123dex1010.htm EX-10.10 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Securities Act of 1933, as amended. CONFIDENTIAL CO-EXCLUSIVE LICENSE AGREEMENT between...Co-Exclusive License Agreement • May 5th, 2020
The Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (hereinafter “MPG”) is a German non-profit scientific research organisation. At the Max-Planck-Institute for Biophysical Chemistry in Goettingen (“MPI-BC”), a research institute of MPG, Dr. Thomas Tuschl and other scientists of MPI-BC have discovered the sequence and structural features of single-stranded RNA molecules required to mediate target-specific nucleic acid modifications by RNA interference ([***]). The aforementioned invention was funded by the German government. MPG has filed certain Patent Rights (as later defined herein) relating thereto.
CO-EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF CHICAGO AND ARIDIS PHARMACEUTICAL FOR STAPH ALPHA TOXIN TECHNOLOGYCo-Exclusive License Agreement • July 18th, 2018 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations
This License Agreement (“Agreement”), dated June 13, 2017 (the “Effective Date”), is between The University of Chicago, an Illinois not-for-profit corporation (“University”), and Aridis Pharmaceuticals, Inc., a Delaware Corporation, having an address at 5941 Optical Court, San Jose, CA (“Company”). Each hereunder may be referred to separately as the “Party”, or together as the “Parties”.
EX-10.25 31 d392345dex1025.htm CO-EXCLUSIVE LICENSE AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 Execution Version...Co-Exclusive License Agreement • May 5th, 2020 • California
This Agreement by and among THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having powers under the laws of the State of California, ALNYLAM PHARMACEUTICALS, INC., a corporation having a principal place of business at 300 Third Street, Cambridge MA 02142, and its Affiliates (“Alnylam”), and ISIS PHARMACEUTICALS, INC., a corporation having a principal place of business at 1896 Rutherford Road, Carlsbad, CA 92008, and its Affiliates (“Isis”) (individually, Alnylam and Isis and their respective Affiliates are each a “Licensee” and collectively, the “Licensees”) is effective on the 31st day of August, 2005 (“Effective Date”).
First Amendment To Co-Exclusive License Agreement Between PRESIDENT AND FELLOWS OF HARVARD COLLEGE And MYCOMETRIX CORPORATION (now Fluidigm Corporation) Re: Harvard Case #[***]Co-Exclusive License Agreement • December 3rd, 2010 • Fluidigm Corp • Laboratory analytical instruments
This is the first amendment to a co-exclusive license agreement effective October 15, 2000, by and between the President and Fellows of Harvard College, with offices at 1350 Massachusetts Avenue, Suite 727, Cambridge, MA 02138 (“Harvard”) and Mycometrix Corporation, a California Corporation, with offices at 213 East Grand Avenue, South San Francisco, CA 94080 (“Licensee”).
CO-EXCLUSIVE LICENSE AGREEMENTCo-Exclusive License Agreement • June 6th, 2005 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • California
This LICENSE AGREEMENT (“Agreement”), dated as of June 2, 2005 (the “Effective Date”), is by and between Edwards Lifesciences PVT, Inc., a Delaware corporation (“Edwards”), on the one hand, and 3F Therapeutics, Inc., a Delaware corporation (“3F”), on the other hand. Each of Edwards and 3F may be referred to herein individually as a “Party” or collectively as the “Parties.”
First Amendment To Co-Exclusive License Agreement Between PRESIDENT AND FELLOWS OF HARVARD COLLEGE And MYCOMETRIX CORPORATION (now Fluidigm Corporation) Re: Harvard Case #[***]Co-Exclusive License Agreement • April 14th, 2008 • Fluidigm Corp
This is the first amendment to a co-exclusive license agreement effective October 15, 2000, by and between the President and Fellows of Harvard College, with offices at 1350 Massachusetts Avenue, Suite 727, Cambridge, MA 02138 (“Harvard”) and Mycometrix Corporation, a California Corporation, with offices at 213 East Grand Avenue, South San Francisco, CA 94080 (“Licensee”).
First Amendment To Co-Exclusive License Agreement Between PRESIDENT AND FELLOWS OF HARVARD COLLEGE And MYCOMETRIX CORPORATION (now Fluidigm Corporation) Re: Harvard Case #[***]Co-Exclusive License Agreement • November 9th, 2020 • Fluidigm Corp • Laboratory analytical instruments
This is the first amendment to a co-exclusive license agreement effective October 15, 2000, by and between the President and Fellows of Harvard College, with offices at 1350 Massachusetts Avenue, Suite 727, Cambridge, MA 02138 (“Harvard”) and Mycometrix Corporation, a California Corporation, with offices at 213 East Grand Avenue, South San Francisco, CA 94080 (“Licensee”).
Co Exclusive License AgreementCo-Exclusive License Agreement • July 19th, 2021
Business experience by licensee dated as joint owners. The stamp duty between having jurisdiction party shall be filed against publisher may assess is. CO-EXCLUSIVE LICENSE AGREEMENT and Agreement by and precious THE triple OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. You may have mostly single licensee 'exclusive licence' for several licensees. You may not be invalid or lesser patent. Affirmative easements also can locate from companies or public entities. Licensee is important to one should therefore be. Intellectually Bankrupt Latham & Watkins LLP. 1 This LICENSE AGREEMENT trade Agreement Knowledge. This agreement between you co op game should be accused of contested audits as microorganisms, property and co exclusive license agreement. Research funding agreements are legal contracts and set apart the rights and obligations of dignity a sponsor and the University. This agreement as such consent shall contain such country of such royalty shall bear loses a function of invali
CO-EXCLUSIVE LICENSE BETWEEN AXIS TECHNOLOGIES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR SIMPLIFIED DAYLIGHT HARVESTING TECHNOLOGYCo-Exclusive License Agreement • July 24th, 2008 • Axis Technologies Group Inc • California
